The usage of monoammonium cysteine glycyrrhizinate sodium chloride injection is intravenous drip, slow drip, and the recommended dosage of the instruction is 100 to 250 ml once a day. Monoammonium cysteine glycyrrhizinate sodium chloride injection has the effect of protecting liver cell membrane, detoxification, antioxidant, anti-inflammatory, rabbit epidemic regulation, anti-hepatic fibrosis, inhibition of viral proliferation, inactivation of virus, clinically, it is mostly used for the treatment of chronic active hepatitis, chronic delayed hepatitis, acute hepatitis, early stage of cirrhosis, hepatic toxicity, etc., and restoring hepatocyte function, and it can be used in allergic diseases as well. The recommended dosage of the drug is as mentioned above, due to the different general conditions of different patients, the severity of the disease and other factors, the specific dosage can not be generalized, the patient should follow the doctor’s instructions to use the drug. It should be noted that the use of Monoammonium Cysteine Glycyrrhizinate Sodium Chloride Injection is prohibited in patients who are allergic to any component of the drug, patients with severe hypokalemia or hypernatremia, patients with renal failure, patients with hypertension, and patients with heart failure. Some patients may experience adverse reactions such as loss of appetite, dry mouth, swelling, nausea, vomiting, abdominal distension, rash, headache, dizziness, palpitations (rapid heartbeat, often accompanied by panic), etc., which are generally mild and do not affect the treatment, and if the discomfort is more serious, you should inform your doctor in time and deal with it accordingly. Monoammonium Cysteine Glycyrrhizinate Sodium Chloride Injection should be used by a professional doctor, and patients should not use the drug on their own to avoid side effects.